Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiesje Pelkmans

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Brain : a Journal of Neurology|November 8, 2024
Astroglial reactivity is a key modulator of Alzheimer's disease pathological progressionWiesje Pelkmans, Juan Domingo Gispert
Human Brain Mapping|June 4, 2019
Gray matter T1-w/T2-w ratios are higher in Alzheimer's diseaseWiesje Pelkmans, Ellen Dicks, Frederik Barkhof, et al.
Alzheimer'S Research & Therapy|August 14, 2021
Tau-related grey matter network breakdown across the Alzheimer's disease continuumWiesje Pelkmans, Rik Ossenkoppele, Ellen Dicks, et al.
Brain Communications|March 21, 2022
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical declineWiesje Pelkmans, Ellen M Vromen, Ellen Dicks, et al.
BMC Geriatrics|November 11, 2023
Is the association between blood pressure and cognition in the oldest-old modified by physical, vascular or brain pathology markers? The EMIF-AD 90 + StudyNienke Legdeur, Justine E Moonen, Maryam Badissi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Neuroimage. Clinical|October 15, 2025
Genetic drivers of hippocampal atrophy highlight the role of APOE functional variants and AD polygenicity in Mild Cognitive ImpairmentNatalia Vilor-Tejedor, Albert Rodrigo, Patricia Genius, et al.
Alzheimer Disease and Associated Disorders|February 24, 2022
The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset DementiaDaniël M van der Doelen, Ron L H Handels, Marissa D Zwan, et al.
Disability and Rehabilitation. Assistive Technology|November 27, 2020
Impact of the FindMyApps program on people with mild cognitive impairment or dementia and their caregivers; an exploratory pilot randomised controlled trialKim M Beentjes, David P Neal, Yvonne J F Kerkhof, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Brain : a Journal of Neurology|November 8, 2024
Astroglial reactivity is a key modulator of Alzheimer's disease pathological progressionWiesje Pelkmans, Juan Domingo Gispert
Human Brain Mapping|June 4, 2019
Gray matter T1-w/T2-w ratios are higher in Alzheimer's diseaseWiesje Pelkmans, Ellen Dicks, Frederik Barkhof, et al.
Alzheimer'S Research & Therapy|August 14, 2021
Tau-related grey matter network breakdown across the Alzheimer's disease continuumWiesje Pelkmans, Rik Ossenkoppele, Ellen Dicks, et al.
Brain Communications|March 21, 2022
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical declineWiesje Pelkmans, Ellen M Vromen, Ellen Dicks, et al.
BMC Geriatrics|November 11, 2023
Is the association between blood pressure and cognition in the oldest-old modified by physical, vascular or brain pathology markers? The EMIF-AD 90 + StudyNienke Legdeur, Justine E Moonen, Maryam Badissi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersWiesje Pelkmans, Mahnaz Shekari, Armand González Escalante, et al.
Neuroimage. Clinical|October 15, 2025
Genetic drivers of hippocampal atrophy highlight the role of APOE functional variants and AD polygenicity in Mild Cognitive ImpairmentNatalia Vilor-Tejedor, Albert Rodrigo, Patricia Genius, et al.
Alzheimer Disease and Associated Disorders|February 24, 2022
The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset DementiaDaniël M van der Doelen, Ron L H Handels, Marissa D Zwan, et al.
Disability and Rehabilitation. Assistive Technology|November 27, 2020
Impact of the FindMyApps program on people with mild cognitive impairment or dementia and their caregivers; an exploratory pilot randomised controlled trialKim M Beentjes, David P Neal, Yvonne J F Kerkhof, et al.
Pageof 2